APA (7th ed.) Citation

Onishi, A., Miyagawa-Hayashino, A., Okamoto, H., Fujino, T., Tsukamoto, T., Mizutani, S., . . . Kuroda, J. (2025). Phosphorylation status and prognostic impacts of RSK2, PDPK1, and AKT in malignant lymphoma. Leukemia & Lymphoma, 66(8), 1413. https://doi.org/10.1080/10428194.2025.2482891

Chicago Style (17th ed.) Citation

Onishi, Akio, Aya Miyagawa-Hayashino, Haruya Okamoto, Takahiro Fujino, Taku Tsukamoto, Shinsuke Mizutani, Yuji Shimura, Eiichi Konishi, and Junya Kuroda. "Phosphorylation Status and Prognostic Impacts of RSK2, PDPK1, and AKT in Malignant Lymphoma." Leukemia & Lymphoma 66, no. 8 (2025): 1413. https://doi.org/10.1080/10428194.2025.2482891.

MLA (9th ed.) Citation

Onishi, Akio, et al. "Phosphorylation Status and Prognostic Impacts of RSK2, PDPK1, and AKT in Malignant Lymphoma." Leukemia & Lymphoma, vol. 66, no. 8, 2025, p. 1413, https://doi.org/10.1080/10428194.2025.2482891.